MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Ionis Pharmaceuticals Company Profile (NASDAQ:IONS)

Consensus Ratings for Ionis Pharmaceuticals (NASDAQ:IONS) (?)
Ratings Breakdown: 1 Sell Rating(s), 6 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Hold (Score: 2.27)
Consensus Price Target: $44.63 (96.67% upside)

Analysts' Ratings History for Ionis Pharmaceuticals (NASDAQ:IONS)
Show:
DateFirmActionRatingPrice TargetActions
5/29/2016JPMorgan Chase & Co.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/29/2016Jefferies GroupReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2016BarclaysLower Price TargetEqual Weight$42.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2016BMO Capital MarketsDowngradeOutperform -> Market Perform$55.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2016Piper JaffrayReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2016Cowen and CompanyReiterated RatingOutperform -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2016Needham & Company LLCReiterated RatingBuy$88.00 -> $55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016Wells FargoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016Leerink SwannLower Price TargetMarket Perform$40.00 -> $39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/22/2016Goldman SachsLower Price Target$65.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2015Deutsche BankSet Price TargetBuy$78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2015Janney Montgomery ScottInitiated CoverageNeutral -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2015Stifel NicolausDowngradeBuy -> Hold$66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2015Brean CapitalDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014LaidlawBoost Price Target$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/31/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha